Entyvio 300 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FRDQ4
Awardee
Awarding agency
Obligated
$39,730

Award facts

Contract value 100% obligated
$39,730.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $39,730 delivery order to DMS Pharmaceutical Group Inc. on April 15, 2026, for ENTYVIO 300 mg vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical product distribution to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order has a firm fixed price and an ultimate completion date of April 16, 2026.

Quick answers

Who was awarded contract SPE2DR26FRDQ4?

SPE2DR26FRDQ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 15, 2026.

How much is contract SPE2DR26FRDQ4 worth?

The government has obligated $39,730 on SPE2DR26FRDQ4.

Is contract SPE2DR26FRDQ4 an order under another contract?

Yes. SPE2DR26FRDQ4 is a delivery order under SPE2DR25D9143, an indefinite delivery contract.

Was contract SPE2DR26FRDQ4 competed?

The extent of competition for SPE2DR26FRDQ4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login